BTIS
LGND icon

BB&T Investment Services’s Ligand Pharmaceuticals LGND Stock Holding History

BB&T Investment Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$26K Hold
297
– – ﹤0.01% 727
2017
Q3 		$26K Hold
297
– – 0.01% 660
2017
Q2 		$24K Buy
297
+81
+38% +$5.67K 0.01% 629
2017
Q1 		$13K Buy
216
+174
+414% +$11.4K 0.01% 670
2016
Q4 		$2K Buy
+42
New +$2.65K ﹤0.01% 699

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BB&T Investment Services's LGND Position: Q4 2017 in Review

BB&T Investment Services held its Ligand Pharmaceuticals (LGND) position steady in Q4 2017 at 297 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #727.

BB&T Investment Services first reported a position in LGND in Q4 2016 and has held it in 5 quarters since. 298 funds tracked by Wall St. Rank hold LGND as of Q4 2017.

  • BB&T Investment Services held 297 shares of Ligand Pharmaceuticals worth $26K as of Q4 2017.
  • BB&T Investment Services left its Ligand Pharmaceuticals share count unchanged in Q4 2017.
  • Ligand Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #727 holding.
  • BB&T Investment Services first reported a position in Ligand Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • 298 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.